Opportunity ID: 78413

General Information

Document Type: Grants Notice
Funding Opportunity Number: DARPA-BAA-11-38
Funding Opportunity Title: Autonomous Diagnostics to Enable Prevention and Therapeutics: Diagnostics on Demand � Point of Care (ADEPT: DxOD -PoC)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Other
Procurement Contract
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
Assistance Listings: 12.910 — Research and Technology Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Mar 14, 2011
Last Updated Date: May 11, 2011
Original Closing Date for Applications: May 17, 2011
Current Closing Date for Applications: May 17, 2011
Archive Date: Jul 18, 2011
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: DARPA – Defense Sciences Office
Description: DARPA is soliciting research proposals to develop advanced nucleic acid and protein tests, automate analysis of fresh and/or stored biospecimens in clinical settings integrated into highly multiplexed platforms that are rapidly reconfigurable for emerging needs.

See attached DARPA-BAA-11-38.

Link to Additional Information: DARPA-BAA-11-38 Solitication Address
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

BAA COORDINATOR
Email:DARPA-BAA-11-38@darpr.mil

Version History

Version Modification Description Updated Date
See attached Modification 1. May 11, 2011
May 11, 2011

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: DARPA-BAA-11-38
Funding Opportunity Title: Autonomous Diagnostics to Enable Prevention and Therapeutics: Diagnostics on Demand � Point of Care (ADEPT: DxOD -PoC)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Other
Procurement Contract
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
Assistance Listings: 12.910 — Research and Technology Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Mar 14, 2011
Last Updated Date: May 11, 2011
Original Closing Date for Applications: May 17, 2011
Current Closing Date for Applications: May 17, 2011
Archive Date: Jul 18, 2011
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: DARPA – Defense Sciences Office
Description: DARPA is soliciting research proposals to develop advanced nucleic acid and protein tests, automate analysis of fresh and/or stored biospecimens in clinical settings integrated into highly multiplexed platforms that are rapidly reconfigurable for emerging needs.

See attached DARPA-BAA-11-38.

Link to Additional Information: DARPA-BAA-11-38 Solitication Address
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

BAA COORDINATOR
Email:DARPA-BAA-11-38@darpr.mil

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: DARPA-BAA-11-38
Funding Opportunity Title: Autonomous Diagnostics to Enable Prevention and Therapeutics: Diagnostics on Demand – Point of Care (ADEPT: DxOD -PoC)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Other
Procurement Contract
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
Assistance Listings: 12.910 — Research and Technology Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 11, 2011
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 17, 2011
Archive Date: Jul 18, 2011
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: DARPA – Defense Sciences Office
Description: DARPA is soliciting research proposals to develop advanced nucleic acid and protein tests, automate analysis of fresh and/or stored biospecimens in clinical settings integrated into highly multiplexed platforms that are rapidly reconfigurable for emerging needs.

See attached DARPA-BAA-11-38.

Link to Additional Information: DARPA-BAA-11-38 Solitication Address
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

BAA COORDINATOR
Email:DARPA-BAA-11-38@darpr.mil

Folder 78413 Full Announcement-1 -> darpa-baa-11-38 dxod-poc.pdf

Folder 78413 Revised Full Announcement-1 -> darpa-baa-11-38 modification 1.pdf

Packages

Agency Contact Information: BAA COORDINATOR
Email: DARPA-BAA-11-38@darpr.mil
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.910 PKG00039910 Mar 14, 2011 May 17, 2011 View

Package 1

Mandatory forms

78413 RR_SF424-1.1.pdf

Optional forms

78413 RR_FedNonFedBudget-1.1.pdf

78413 RR_FedNonFed_SubawardBudget-1.2.pdf

78413 RR_OtherProjectInfo-1.1.pdf

78413 RR_Budget-1.1.pdf

78413 RR_KeyPersonExpanded-1.1.pdf

78413 RR_PerformanceSite-1.1.pdf

78413 RR_SubawardBudget-1.2.pdf

2025-07-12T16:58:51-05:00

Share This Post, Choose Your Platform!

About the Author: